Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

NCT02212457 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1063

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Bexsero
OTHER: Saline Placebo
BIOLOGICAL: Havrix
BIOLOGICAL: MenABCWY

Sponsor

GlaxoSmithKline